News headlines about RTI Surgical (NASDAQ:RTIX) have trended somewhat positive recently, according to Accern Sentiment. Accern rates the sentiment of press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. RTI Surgical earned a daily sentiment score of 0.05 on Accern’s scale. Accern also assigned media stories about the medical equipment provider an impact score of 45.5508760424668 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
These are some of the news articles that may have effected Accern’s scoring:
- RTI Surgical, Inc. (RTIX) Expected to Announce Quarterly Sales of $66.27 Million (americanbankingnews.com)
- Zacks: Brokerages Expect RTI Surgical Inc (RTIX) to Post $0.01 EPS (americanbankingnews.com)
- United Continental Holdings (NYSE:UAL) Experiences Heavy Trading Volume (topactu.net)
- HeartWare International (HTWR) & RTI Surgical (RTIX) Critical Review (americanbankingnews.com)
RTIX has been the topic of a number of analyst reports. Zacks Investment Research upgraded RTI Surgical from a “hold” rating to a “buy” rating and set a $6.25 target price on the stock in a research report on Wednesday, June 28th. BidaskClub cut RTI Surgical from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 25th. Finally, ValuEngine upgraded RTI Surgical from a “sell” rating to a “hold” rating in a research report on Friday, June 2nd.
RTI Surgical (NASDAQ RTIX) remained flat at $4.50 during midday trading on Tuesday. 81,997 shares of the stock traded hands. The stock’s 50 day moving average price is $4.96 and its 200 day moving average price is $4.70. RTI Surgical has a 12-month low of $2.50 and a 12-month high of $6.00. The firm’s market capitalization is $265.65 million.
RTI Surgical (NASDAQ:RTIX) last issued its quarterly earnings results on Tuesday, August 8th. The medical equipment provider reported $0.02 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.02. RTI Surgical had a negative net margin of 6.53% and a positive return on equity of 2.07%. The business had revenue of $72.10 million for the quarter, compared to analyst estimates of $70.25 million. The firm’s revenue for the quarter was up 6.7% on a year-over-year basis. On average, equities analysts expect that RTI Surgical will post $0.06 earnings per share for the current fiscal year.
In related news, Director Nicholas J. Valeriani bought 5,500 shares of the stock in a transaction on Monday, August 21st. The shares were bought at an average cost of $4.70 per share, for a total transaction of $25,850.00. Following the completion of the transaction, the director now owns 47,754 shares of the company’s stock, valued at approximately $224,443.80. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP John N. Varela bought 12,000 shares of the stock in a transaction on Friday, August 11th. The shares were bought at an average price of $4.85 per share, for a total transaction of $58,200.00. Following the completion of the transaction, the executive vice president now directly owns 47,998 shares of the company’s stock, valued at approximately $232,790.30. The disclosure for this purchase can be found here. Insiders own 4.90% of the company’s stock.
RTI Surgical Company Profile
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.